ADVERTISEMENT

Taguig's active COVID-19 cases down to 298

Published Feb 17, 2022 09:39 am

Taguig City’s active coronavirus disease (COVID-19) cases decreased to 298 from peaking to 598 in the previous days.

The City Epidemiology and Disease Surveillance Unit (CEDSU) reported on Feb. 16 that as of Feb. 15, Taguig has 298 active COVID-19 cases out of 64,228 confirmed cases, 63,466 recoveries and 464 deaths since 2020.

On Feb. 15, Taguig recorded 143 new COVID-19 cases, 95 recoveries and zero deaths.

Personnel from the Taguig City Fire Station and Containment Cluster implementing quarantine rules in Barangay Central Signal in Taguig on Feb. 16. (BFP-Taguig)

Of the barangays, Fort Bonifacio registered the highest active cases with 47 followed by Ususan, 29; Western Bicutan, 24; Pinagsama, 21; and Lower Bicutan and North Signal, 18 each.

The Taguig City government tallied 1,025 new COVID-19 cases in the last seven days from Feb. 9 to 15, or an average of 146 new cases per day. In the same period, 1,238 COVID-19 patients have recovered, or 177 individuals per day.

As of Feb. 15, the Taguig City government said there are now 795,435 fully vaccinated individuals in the city consisting of 760,576 who got inoculated in Taguig hubs and 34,859 in private hubs.

This is equivalent to 90 percent of the estimated population of 882,512 in Taguig based on the projections of the Department of Health.

In addition, 864,970 individuals have received their first dose of the COVID-19 vaccine, or 98 percent of the estimated population.

Based on OCTA Research’s data, there were 632 new cases in the NCR on Feb. 16, higher than its projections. Dr. Guido David said, “With mostly fresh cases, this feels like a Valentine spike.”

During the “Laging Handa” public briefing on Feb. 15, David said as of Feb. 14, the positivity rate in the National Capital Region was only 6.8 percent from 8.5 percent on Feb. 13.

“That is good news, that it continues to go down. We are somewhat near to the five percent benchmark by the World Health Organization for positivity rate,” he said.

He estimated that by March 1, the five-percent benchmark can be achieved.

David said the average daily attack rate (ADAR) in Metro Manila stood at 3.96 and based on OCTA Research’s indicators, this will go down to low-risk ADAR possibly next week or in two weeks at the latest.

Related Tags

taguig OCTA Research Taguig COVID-19 cases Dr. Guido David
ADVERTISEMENT
.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1561_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1562_widget.title }}

.most-popular .layout-ratio{ padding-bottom: 79.13%; } @media (min-width: 768px) and (max-width: 1024px) { .widget-title { font-size: 15px !important; } }

{{ articles_filter_1563_widget.title }}

{{ articles_filter_1564_widget.title }}

.mb-article-details { position: relative; } .mb-article-details .article-body-preview, .mb-article-details .article-body-summary{ font-size: 17px; line-height: 30px; font-family: "Libre Caslon Text", serif; color: #000; } .mb-article-details .article-body-preview iframe , .mb-article-details .article-body-summary iframe{ width: 100%; margin: auto; } .read-more-background { background: linear-gradient(180deg, color(display-p3 1.000 1.000 1.000 / 0) 13.75%, color(display-p3 1.000 1.000 1.000 / 0.8) 30.79%, color(display-p3 1.000 1.000 1.000) 72.5%); position: absolute; height: 200px; width: 100%; bottom: 0; display: flex; justify-content: center; align-items: center; padding: 0; } .read-more-background a{ color: #000; } .read-more-btn { padding: 17px 45px; font-family: Inter; font-weight: 700; font-size: 18px; line-height: 16px; text-align: center; vertical-align: middle; border: 1px solid black; background-color: white; } .hidden { display: none; }
function initializeAllSwipers() { // Get all hidden inputs with cms_article_id document.querySelectorAll('[id^="cms_article_id_"]').forEach(function (input) { const cmsArticleId = input.value; const articleSelector = '#article-' + cmsArticleId + ' .body_images'; const swiperElement = document.querySelector(articleSelector); if (swiperElement && !swiperElement.classList.contains('swiper-initialized')) { new Swiper(articleSelector, { loop: true, pagination: false, navigation: { nextEl: '#article-' + cmsArticleId + ' .swiper-button-next', prevEl: '#article-' + cmsArticleId + ' .swiper-button-prev', }, }); } }); } setTimeout(initializeAllSwipers, 3000); const intersectionObserver = new IntersectionObserver( (entries) => { entries.forEach((entry) => { if (entry.isIntersecting) { const newUrl = entry.target.getAttribute("data-url"); if (newUrl) { history.pushState(null, null, newUrl); let article = entry.target; // Extract metadata const author = article.querySelector('.author-section').textContent.replace('By', '').trim(); const section = article.querySelector('.section-info ').textContent.replace(' ', ' '); const title = article.querySelector('.article-title h1').textContent; // Parse URL for Chartbeat path format const parsedUrl = new URL(newUrl, window.location.origin); const cleanUrl = parsedUrl.host + parsedUrl.pathname; // Update Chartbeat configuration if (typeof window._sf_async_config !== 'undefined') { window._sf_async_config.path = cleanUrl; window._sf_async_config.sections = section; window._sf_async_config.authors = author; } // Track virtual page view with Chartbeat if (typeof pSUPERFLY !== 'undefined' && typeof pSUPERFLY.virtualPage === 'function') { try { pSUPERFLY.virtualPage({ path: cleanUrl, title: title, sections: section, authors: author }); } catch (error) { console.error('ping error', error); } } // Optional: Update document title if (title && title !== document.title) { document.title = title; } } } }); }, { threshold: 0.1 } ); function showArticleBody(button) { const article = button.closest("article"); const summary = article.querySelector(".article-body-summary"); const body = article.querySelector(".article-body-preview"); const readMoreSection = article.querySelector(".read-more-background"); // Hide summary and read-more section summary.style.display = "none"; readMoreSection.style.display = "none"; // Show the full article body body.classList.remove("hidden"); } document.addEventListener("DOMContentLoaded", () => { let loadCount = 0; // Track how many times articles are loaded const offset = [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]; // Offset values const currentUrl = window.location.pathname.substring(1); let isLoading = false; // Prevent multiple calls if (!currentUrl) { console.log("Current URL is invalid."); return; } const sentinel = document.getElementById("load-more-sentinel"); if (!sentinel) { console.log("Sentinel element not found."); return; } function isSentinelVisible() { const rect = sentinel.getBoundingClientRect(); return ( rect.top < window.innerHeight && rect.bottom >= 0 ); } function onScroll() { if (isLoading) return; if (isSentinelVisible()) { if (loadCount >= offset.length) { console.log("Maximum load attempts reached."); window.removeEventListener("scroll", onScroll); return; } isLoading = true; const currentOffset = offset[loadCount]; window.loadMoreItems().then(() => { let article = document.querySelector('#widget_1690 > div:nth-last-of-type(2) article'); intersectionObserver.observe(article) loadCount++; }).catch(error => { console.error("Error loading more items:", error); }).finally(() => { isLoading = false; }); } } window.addEventListener("scroll", onScroll); });

Sign up by email to receive news.